Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $591M; returns 1 day +0.6%, 1 week +1.5%, 1 year -14.9%.

Fulgent Genetics Inc. (FLGT) is a technology-based company primarily focused on providing comprehensive genetic testing solutions through its proprietary Next-Generation Sequencing (NGS) platform, operating mainly in the United States. Its laboratory services business is segmented into Precision Diagnostics, Anatomic Pathology, and BioPharma Services.

Groups FLGT belongs to

• Healthcare
• Shrinking Share Count
• Biotechnology
• Life Sciences
• Precision Medicine
• Health Diagnostics and Imaging
• Oncology
• Healthcare Services
• Clinical Stage Biotech
• Cancer Therapeutics
• Rare Diseases
• Life Sciences Tools & Services
• Biopharmaceutical

FLGT financial model: income statement, cash flow and balance sheet